as 11-22-2024 4:00pm EST
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Founded: | N/A | Country: | Canada |
Employees: | N/A | City: | N/A |
Market Cap: | 186.3M | IPO Year: | N/A |
Target Price: | $11.40 | AVG Volume (30 days): | 45.3K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.33 | EPS Growth: | N/A |
52 Week Low/High: | $7.11 - $11.42 | Next Earning Date: | 11-07-2024 |
Revenue: | $8,984,000 | Revenue Growth: | 39.35% |
Revenue Growth (this year): | 56.11% | Revenue Growth (next year): | 171.96% |
PROF Breaking Stock News: Dive into PROF Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
Simply Wall St.
15 days ago
GuruFocus.com
16 days ago
GlobeNewswire
17 days ago
GuruFocus.com
18 days ago
GlobeNewswire
20 days ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
The information presented on this page, "PROF Profound Medical Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.